Page 1

Ipca Laboratories Limited Regd . Office : 48 , Kandivli Industrial Estate , Kandivli ( W ) , Mumbai 400 067 CIN : L24239MH1949PLC007837 Tel : +91 22 6647 4444 , E - mail : investors@ipca.com Website : www.ipca.com STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30 , 2021 Particulars ( Crores ) Year Ended Sr. No. Revenue from operations II Other Income III Total Income ( I + ll ) Quarter Ended June 30 , 2021 March 31 , 2021 June 30 , 2020 March 31 , 2021 Unaudited Audited * Unaudited Audited 1478.60 1040.92 1485.25 13.61 19.91 11.68 5139.16 62.24 1492.21 1060.83 1496.93 5201.40 IV Expenses a ) Cost of materials consumed 404.08 409.30 362.73 1555.53 b ) Purchases of stock - in - trade 52.14 69.93 33.37 c ) Changes in inventories of finished goods , 41.97 ( 178.15 ) 11.34 197.68 ( 170.73 ) work - in - progress and stock - in - trade d ) Employee benefits expense 280.64 237.80 241.92 948.84 e ) Finance costs 1.26 2.31 2.46 8.14 ( f ) Depreciation and amortisation expense 49.96 48.57 45.23 g ) Other expenses 305.79 285.40 247.94 187.72 1094.26 Total Expenses ( IV ) 1135.84 875.16 944.99 3821.44 V Profit before exceptional items and tax ( III - IV ) 356.37 185.67 551.94 1379.96 VI Exceptional items VII Profit before tax ( V - VI ) 356.37 185.67 551.94 1379.96 Vill Tax Expense -Current tax 62.50 36.28 101.50 244.98 -Short ( Excess ) provision of earlier years -Deferred tax liability / ( asset ) including MAT credit 9.15 ( 2.09 ) ( 3.20 ) ( 5.79 ) IX Profit for the period from continuing operations ( VII - VIII ) 284.72 151.48 453.64 1140.77 Other Comprehensive Income A ( i ) Items that will not be reclassified to profit or loss . - Actuarial gain / ( loss ) ( ii ) Income tax relating to items that will not be reclassified to profit or loss ( 0.37 ) 0.98 ( 1.31 ) ( 0.19 ) 0.06 ( 0.18 ) 0.23 0.03 B ( i ) Items that will be reclassified to profit or loss - Exchange difference in translating the financial statement of foreign operation ( 0.13 ) ( 0.18 ) 0.13 ( 0.36 ) - Gain / ( loss ) on cash flow hedge 0.23 0.14 0.03 0.65 ( ii ) Income tax relating to items that will be reclassified to ( 0.02 ) 0.01 ( 0.03 ) ( 0.05 ) profit or loss Other Comprehensive Income / ( Loss ) for the period net of tax ( X ) ( 0.23 ) 0.77 ( 0.95 ) 0.08 X X X X XI Total Comprehensive Income for the period ( IX + X ) 284.49 152.25 452.69 1140.85 XII Paid - up equity share capital ( Face value of * 2 / - each ) 25.37 25.37 25.27 25.37 XIII Other Equity 4727.35 XIV Net Worth 4752.72 XV Earnings per share ( of 2 / - each ) ( Not annualised ) : Basic ( * ) 22.45 11.94 35.90 90.08 Diluted ( ) 22.45 11.94 35.87 90.08 ries Laboratoria Kipca ipca Limited